Obama Pushing For “Better Prices” For Part D Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
White House finds additional $313 billion in savings – $75 billion from drugs – to pay for expanded health care reform.
You may also be interested in...
FOB Savings Reduced To $6.4 Bil. In Revised Budget Outlook; Total Drug Savings, $100 Bil.
The administration's expectations for savings from follow-on biologics that can be applied to health care reform are clarified by the mid-year budget review and outlook released by OMB Aug. 25.
FOB Savings Reduced To $6.4 Bil. In Revised Budget Outlook; Total Drug Savings, $100 Bil.
The administration's expectations for savings from follow-on biologics that can be applied to health care reform are clarified by the mid-year budget review and outlook released by OMB Aug. 25.
House Health Reform Bill Increases Drug Rebates, Drops Part D Donut Hole
The House health care reform bill asks pharmaceutical manufacturers to pay their share of the cost of expanding health care coverage by paying higher rebates on more drugs